Global Gabapentin Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Gabapentin market size is predicted to grow from US$ 1563 million in 2025 to US$ 1746 million in 2031; it is expected to grow at a CAGR of 1.9% from 2025 to 2031.
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
Global Gabapentin key players include Novartis, TEVA, Mylan, Pfizer, etc. Global top four manufacturers hold a share about 20%.
North America is the largest market, with a share over 30%, followed by Asia-Pacific, and Europe, both have a share about 50 percent.
In terms of product, Capsule is the largest segment, with a share about 55%. And in terms of application, the largest application is Epilepsy, followed by Neuropathic Pain, Restless Legs Syndrome, etc.
LP Information, Inc. (LPI) ' newest research report, the “Gabapentin Industry Forecast” looks at past sales and reviews total world Gabapentin sales in 2024, providing a comprehensive analysis by region and market sector of projected Gabapentin sales for 2025 through 2031. With Gabapentin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gabapentin industry.
This Insight Report provides a comprehensive analysis of the global Gabapentin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gabapentin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gabapentin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gabapentin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gabapentin.
This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Gabapentin market?
What factors are driving Gabapentin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gabapentin market opportunities vary by end market size?
How does Gabapentin break out by Type, by Application?
The global Gabapentin market size is predicted to grow from US$ 1563 million in 2025 to US$ 1746 million in 2031; it is expected to grow at a CAGR of 1.9% from 2025 to 2031.
Gabapentin is a medication used to treat epilepsy, neuropathic pain, hot flashes, and restless legs syndrome. In epilepsy, it may be used for those with partial seizures. It is recommended as one of a number of first line medications for the treatment of neuropathic pain in diabetic neuropathy, postherpetic neuralgia, and central neuropathic pain.
Global Gabapentin key players include Novartis, TEVA, Mylan, Pfizer, etc. Global top four manufacturers hold a share about 20%.
North America is the largest market, with a share over 30%, followed by Asia-Pacific, and Europe, both have a share about 50 percent.
In terms of product, Capsule is the largest segment, with a share about 55%. And in terms of application, the largest application is Epilepsy, followed by Neuropathic Pain, Restless Legs Syndrome, etc.
LP Information, Inc. (LPI) ' newest research report, the “Gabapentin Industry Forecast” looks at past sales and reviews total world Gabapentin sales in 2024, providing a comprehensive analysis by region and market sector of projected Gabapentin sales for 2025 through 2031. With Gabapentin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gabapentin industry.
This Insight Report provides a comprehensive analysis of the global Gabapentin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gabapentin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gabapentin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gabapentin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gabapentin.
This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Capsule
- Tablet
- Epilepsy
- Neuropathic Pain
- Restless Legs Syndrome
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Assertio Therapeutics
- TEVA
- Mylan
- Arbor Pharma
- Novartis
- Apotex
- Sun Pharmaceutical
- Aurobindo Pharma
- Intas
- Amneal
- Marksans Pharma
- Glenmark
- Alkem
- Jiangsu Enhua
- Jiangsu Hengrui
- Sailike
What is the 10-year outlook for the global Gabapentin market?
What factors are driving Gabapentin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Gabapentin market opportunities vary by end market size?
How does Gabapentin break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gabapentin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Gabapentin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Gabapentin by Country/Region, 2020, 2024 & 2031
2.2 Gabapentin Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Gabapentin Sales by Type
2.3.1 Global Gabapentin Sales Market Share by Type (2020-2025)
2.3.2 Global Gabapentin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Gabapentin Sale Price by Type (2020-2025)
2.4 Gabapentin Segment by Application
2.4.1 Epilepsy
2.4.2 Neuropathic Pain
2.4.3 Restless Legs Syndrome
2.4.4 Others
2.5 Gabapentin Sales by Application
2.5.1 Global Gabapentin Sale Market Share by Application (2020-2025)
2.5.2 Global Gabapentin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Gabapentin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Gabapentin Breakdown Data by Company
3.1.1 Global Gabapentin Annual Sales by Company (2020-2025)
3.1.2 Global Gabapentin Sales Market Share by Company (2020-2025)
3.2 Global Gabapentin Annual Revenue by Company (2020-2025)
3.2.1 Global Gabapentin Revenue by Company (2020-2025)
3.2.2 Global Gabapentin Revenue Market Share by Company (2020-2025)
3.3 Global Gabapentin Sale Price by Company
3.4 Key Manufacturers Gabapentin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gabapentin Product Location Distribution
3.4.2 Players Gabapentin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GABAPENTIN BY GEOGRAPHIC REGION
4.1 World Historic Gabapentin Market Size by Geographic Region (2020-2025)
4.1.1 Global Gabapentin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Gabapentin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Gabapentin Market Size by Country/Region (2020-2025)
4.2.1 Global Gabapentin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Gabapentin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gabapentin Sales Growth
4.4 APAC Gabapentin Sales Growth
4.5 Europe Gabapentin Sales Growth
4.6 Middle East & Africa Gabapentin Sales Growth
5 AMERICAS
5.1 Americas Gabapentin Sales by Country
5.1.1 Americas Gabapentin Sales by Country (2020-2025)
5.1.2 Americas Gabapentin Revenue by Country (2020-2025)
5.2 Americas Gabapentin Sales by Type (2020-2025)
5.3 Americas Gabapentin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gabapentin Sales by Region
6.1.1 APAC Gabapentin Sales by Region (2020-2025)
6.1.2 APAC Gabapentin Revenue by Region (2020-2025)
6.2 APAC Gabapentin Sales by Type (2020-2025)
6.3 APAC Gabapentin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gabapentin by Country
7.1.1 Europe Gabapentin Sales by Country (2020-2025)
7.1.2 Europe Gabapentin Revenue by Country (2020-2025)
7.2 Europe Gabapentin Sales by Type (2020-2025)
7.3 Europe Gabapentin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gabapentin by Country
8.1.1 Middle East & Africa Gabapentin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Gabapentin Revenue by Country (2020-2025)
8.2 Middle East & Africa Gabapentin Sales by Type (2020-2025)
8.3 Middle East & Africa Gabapentin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gabapentin
10.3 Manufacturing Process Analysis of Gabapentin
10.4 Industry Chain Structure of Gabapentin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gabapentin Distributors
11.3 Gabapentin Customer
12 WORLD FORECAST REVIEW FOR GABAPENTIN BY GEOGRAPHIC REGION
12.1 Global Gabapentin Market Size Forecast by Region
12.1.1 Global Gabapentin Forecast by Region (2026-2031)
12.1.2 Global Gabapentin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Gabapentin Forecast by Type (2026-2031)
12.7 Global Gabapentin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Gabapentin Product Portfolios and Specifications
13.1.3 Pfizer Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Assertio Therapeutics
13.2.1 Assertio Therapeutics Company Information
13.2.2 Assertio Therapeutics Gabapentin Product Portfolios and Specifications
13.2.3 Assertio Therapeutics Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Assertio Therapeutics Main Business Overview
13.2.5 Assertio Therapeutics Latest Developments
13.3 TEVA
13.3.1 TEVA Company Information
13.3.2 TEVA Gabapentin Product Portfolios and Specifications
13.3.3 TEVA Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 TEVA Main Business Overview
13.3.5 TEVA Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Gabapentin Product Portfolios and Specifications
13.4.3 Mylan Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Arbor Pharma
13.5.1 Arbor Pharma Company Information
13.5.2 Arbor Pharma Gabapentin Product Portfolios and Specifications
13.5.3 Arbor Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Arbor Pharma Main Business Overview
13.5.5 Arbor Pharma Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Gabapentin Product Portfolios and Specifications
13.6.3 Novartis Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Apotex
13.7.1 Apotex Company Information
13.7.2 Apotex Gabapentin Product Portfolios and Specifications
13.7.3 Apotex Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Apotex Main Business Overview
13.7.5 Apotex Latest Developments
13.8 Sun Pharmaceutical
13.8.1 Sun Pharmaceutical Company Information
13.8.2 Sun Pharmaceutical Gabapentin Product Portfolios and Specifications
13.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sun Pharmaceutical Main Business Overview
13.8.5 Sun Pharmaceutical Latest Developments
13.9 Aurobindo Pharma
13.9.1 Aurobindo Pharma Company Information
13.9.2 Aurobindo Pharma Gabapentin Product Portfolios and Specifications
13.9.3 Aurobindo Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Aurobindo Pharma Main Business Overview
13.9.5 Aurobindo Pharma Latest Developments
13.10 Intas
13.10.1 Intas Company Information
13.10.2 Intas Gabapentin Product Portfolios and Specifications
13.10.3 Intas Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Intas Main Business Overview
13.10.5 Intas Latest Developments
13.11 Amneal
13.11.1 Amneal Company Information
13.11.2 Amneal Gabapentin Product Portfolios and Specifications
13.11.3 Amneal Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Amneal Main Business Overview
13.11.5 Amneal Latest Developments
13.12 Marksans Pharma
13.12.1 Marksans Pharma Company Information
13.12.2 Marksans Pharma Gabapentin Product Portfolios and Specifications
13.12.3 Marksans Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Marksans Pharma Main Business Overview
13.12.5 Marksans Pharma Latest Developments
13.13 Glenmark
13.13.1 Glenmark Company Information
13.13.2 Glenmark Gabapentin Product Portfolios and Specifications
13.13.3 Glenmark Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Glenmark Main Business Overview
13.13.5 Glenmark Latest Developments
13.14 Alkem
13.14.1 Alkem Company Information
13.14.2 Alkem Gabapentin Product Portfolios and Specifications
13.14.3 Alkem Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Alkem Main Business Overview
13.14.5 Alkem Latest Developments
13.15 Jiangsu Enhua
13.15.1 Jiangsu Enhua Company Information
13.15.2 Jiangsu Enhua Gabapentin Product Portfolios and Specifications
13.15.3 Jiangsu Enhua Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Jiangsu Enhua Main Business Overview
13.15.5 Jiangsu Enhua Latest Developments
13.16 Jiangsu Hengrui
13.16.1 Jiangsu Hengrui Company Information
13.16.2 Jiangsu Hengrui Gabapentin Product Portfolios and Specifications
13.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Jiangsu Hengrui Main Business Overview
13.16.5 Jiangsu Hengrui Latest Developments
13.17 Sailike
13.17.1 Sailike Company Information
13.17.2 Sailike Gabapentin Product Portfolios and Specifications
13.17.3 Sailike Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Sailike Main Business Overview
13.17.5 Sailike Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Gabapentin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Gabapentin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players ofTablet
Table 5. Global Gabapentin Sales byType (2020-2025) & (M Unit)
Table 6. Global Gabapentin Sales Market Share byType (2020-2025)
Table 7. Global Gabapentin Revenue byType (2020-2025) & ($ million)
Table 8. Global Gabapentin Revenue Market Share byType (2020-2025)
Table 9. Global Gabapentin Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Gabapentin Sale by Application (2020-2025) & (M Unit)
Table 11. Global Gabapentin Sale Market Share by Application (2020-2025)
Table 12. Global Gabapentin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Gabapentin Revenue Market Share by Application (2020-2025)
Table 14. Global Gabapentin Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Gabapentin Sales by Company (2020-2025) & (M Unit)
Table 16. Global Gabapentin Sales Market Share by Company (2020-2025)
Table 17. Global Gabapentin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Gabapentin Revenue Market Share by Company (2020-2025)
Table 19. Global Gabapentin Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Gabapentin Producing Area Distribution and Sales Area
Table 21. Players Gabapentin Products Offered
Table 22. Gabapentin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Gabapentin Sales by Geographic Region (2020-2025) & (M Unit)
Table 26. Global Gabapentin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Gabapentin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Gabapentin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Gabapentin Sales by Country/Region (2020-2025) & (M Unit)
Table 30. Global Gabapentin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Gabapentin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Gabapentin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Gabapentin Sales by Country (2020-2025) & (M Unit)
Table 34. Americas Gabapentin Sales Market Share by Country (2020-2025)
Table 35. Americas Gabapentin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Gabapentin Sales byType (2020-2025) & (M Unit)
Table 37. Americas Gabapentin Sales by Application (2020-2025) & (M Unit)
Table 38. APAC Gabapentin Sales by Region (2020-2025) & (M Unit)
Table 39. APAC Gabapentin Sales Market Share by Region (2020-2025)
Table 40. APAC Gabapentin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Gabapentin Sales byType (2020-2025) & (M Unit)
Table 42. APAC Gabapentin Sales by Application (2020-2025) & (M Unit)
Table 43. Europe Gabapentin Sales by Country (2020-2025) & (M Unit)
Table 44. Europe Gabapentin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Gabapentin Sales byType (2020-2025) & (M Unit)
Table 46. Europe Gabapentin Sales by Application (2020-2025) & (M Unit)
Table 47. Middle East & Africa Gabapentin Sales by Country (2020-2025) & (M Unit)
Table 48. Middle East & Africa Gabapentin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Gabapentin Sales byType (2020-2025) & (M Unit)
Table 50. Middle East & Africa Gabapentin Sales by Application (2020-2025) & (M Unit)
Table 51. Key Market Drivers & Growth Opportunities of Gabapentin
Table 52. Key Market Challenges & Risks of Gabapentin
Table 53. Key IndustryTrends of Gabapentin
Table 54. Gabapentin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Gabapentin Distributors List
Table 57. Gabapentin Customer List
Table 58. Global Gabapentin SalesForecast by Region (2026-2031) & (M Unit)
Table 59. Global Gabapentin RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Gabapentin SalesForecast by Country (2026-2031) & (M Unit)
Table 61. Americas Gabapentin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Gabapentin SalesForecast by Region (2026-2031) & (M Unit)
Table 63. APAC Gabapentin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Gabapentin SalesForecast by Country (2026-2031) & (M Unit)
Table 65. Europe Gabapentin RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Gabapentin SalesForecast by Country (2026-2031) & (M Unit)
Table 67. Middle East & Africa Gabapentin RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Gabapentin SalesForecast byType (2026-2031) & (M Unit)
Table 69. Global Gabapentin RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Gabapentin SalesForecast by Application (2026-2031) & (M Unit)
Table 71. Global Gabapentin RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Gabapentin Product Portfolios and Specifications
Table 74. Pfizer Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. AssertioTherapeutics Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 78. AssertioTherapeutics Gabapentin Product Portfolios and Specifications
Table 79. AssertioTherapeutics Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. AssertioTherapeutics Main Business
Table 81. AssertioTherapeutics Latest Developments
Table 82.TEVA Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 83.TEVA Gabapentin Product Portfolios and Specifications
Table 84.TEVA Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85.TEVA Main Business
Table 86.TEVA Latest Developments
Table 87. Mylan Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 88. Mylan Gabapentin Product Portfolios and Specifications
Table 89. Mylan Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Mylan Main Business
Table 91. Mylan Latest Developments
Table 92. Arbor Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 93. Arbor Pharma Gabapentin Product Portfolios and Specifications
Table 94. Arbor Pharma Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Arbor Pharma Main Business
Table 96. Arbor Pharma Latest Developments
Table 97. Novartis Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis Gabapentin Product Portfolios and Specifications
Table 99. Novartis Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Novartis Main Business
Table 101. Novartis Latest Developments
Table 102. Apotex Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 103. Apotex Gabapentin Product Portfolios and Specifications
Table 104. Apotex Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Apotex Main Business
Table 106. Apotex Latest Developments
Table 107. Sun Pharmaceutical Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 108. Sun Pharmaceutical Gabapentin Product Portfolios and Specifications
Table 109. Sun Pharmaceutical Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Sun Pharmaceutical Main Business
Table 111. Sun Pharmaceutical Latest Developments
Table 112. Aurobindo Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 113. Aurobindo Pharma Gabapentin Product Portfolios and Specifications
Table 114. Aurobindo Pharma Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Aurobindo Pharma Main Business
Table 116. Aurobindo Pharma Latest Developments
Table 117. Intas Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 118. Intas Gabapentin Product Portfolios and Specifications
Table 119. Intas Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Intas Main Business
Table 121. Intas Latest Developments
Table 122. Amneal Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 123. Amneal Gabapentin Product Portfolios and Specifications
Table 124. Amneal Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Amneal Main Business
Table 126. Amneal Latest Developments
Table 127. Marksans Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 128. Marksans Pharma Gabapentin Product Portfolios and Specifications
Table 129. Marksans Pharma Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Marksans Pharma Main Business
Table 131. Marksans Pharma Latest Developments
Table 132. Glenmark Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 133. Glenmark Gabapentin Product Portfolios and Specifications
Table 134. Glenmark Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Glenmark Main Business
Table 136. Glenmark Latest Developments
Table 137. Alkem Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 138. Alkem Gabapentin Product Portfolios and Specifications
Table 139. Alkem Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Alkem Main Business
Table 141. Alkem Latest Developments
Table 142. Jiangsu Enhua Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 143. Jiangsu Enhua Gabapentin Product Portfolios and Specifications
Table 144. Jiangsu Enhua Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Jiangsu Enhua Main Business
Table 146. Jiangsu Enhua Latest Developments
Table 147. Jiangsu Hengrui Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 148. Jiangsu Hengrui Gabapentin Product Portfolios and Specifications
Table 149. Jiangsu Hengrui Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 150. Jiangsu Hengrui Main Business
Table 151. Jiangsu Hengrui Latest Developments
Table 152. Sailike Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 153. Sailike Gabapentin Product Portfolios and Specifications
Table 154. Sailike Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 155. Sailike Main Business
Table 156. Sailike Latest Developments
LIST OFFIGURES
Figure 1. Picture of Gabapentin
Figure 2. Gabapentin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gabapentin Sales Growth Rate 2020-2031 (M Unit)
Figure 7. Global Gabapentin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Gabapentin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Gabapentin Sales Market Share by Country/Region (2024)
Figure 10. Gabapentin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Capsule
Figure 12. Product Picture ofTablet
Figure 13. Global Gabapentin Sales Market Share byType in 2025
Figure 14. Global Gabapentin Revenue Market Share byType (2020-2025)
Figure 15. Gabapentin Consumed in Epilepsy
Figure 16. Global Gabapentin Market: Epilepsy (2020-2025) & (M Unit)
Figure 17. Gabapentin Consumed in Neuropathic Pain
Figure 18. Global Gabapentin Market: Neuropathic Pain (2020-2025) & (M Unit)
Figure 19. Gabapentin Consumed in Restless Legs Syndrome
Figure 20. Global Gabapentin Market: Restless Legs Syndrome (2020-2025) & (M Unit)
Figure 21. Gabapentin Consumed in Others
Figure 22. Global Gabapentin Market: Others (2020-2025) & (M Unit)
Figure 23. Global Gabapentin Sale Market Share by Application (2024)
Figure 24. Global Gabapentin Revenue Market Share by Application in 2025
Figure 25. Gabapentin Sales by Company in 2025 (M Unit)
Figure 26. Global Gabapentin Sales Market Share by Company in 2025
Figure 27. Gabapentin Revenue by Company in 2025 ($ millions)
Figure 28. Global Gabapentin Revenue Market Share by Company in 2025
Figure 29. Global Gabapentin Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Gabapentin Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Gabapentin Sales 2020-2025 (M Unit)
Figure 32. Americas Gabapentin Revenue 2020-2025 ($ millions)
Figure 33. APAC Gabapentin Sales 2020-2025 (M Unit)
Figure 34. APAC Gabapentin Revenue 2020-2025 ($ millions)
Figure 35. Europe Gabapentin Sales 2020-2025 (M Unit)
Figure 36. Europe Gabapentin Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Gabapentin Sales 2020-2025 (M Unit)
Figure 38. Middle East & Africa Gabapentin Revenue 2020-2025 ($ millions)
Figure 39. Americas Gabapentin Sales Market Share by Country in 2025
Figure 40. Americas Gabapentin Revenue Market Share by Country (2020-2025)
Figure 41. Americas Gabapentin Sales Market Share byType (2020-2025)
Figure 42. Americas Gabapentin Sales Market Share by Application (2020-2025)
Figure 43. United States Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Gabapentin Sales Market Share by Region in 2025
Figure 48. APAC Gabapentin Revenue Market Share by Region (2020-2025)
Figure 49. APAC Gabapentin Sales Market Share byType (2020-2025)
Figure 50. APAC Gabapentin Sales Market Share by Application (2020-2025)
Figure 51. China Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 55. India Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Gabapentin Sales Market Share by Country in 2025
Figure 59. Europe Gabapentin Revenue Market Share by Country (2020-2025)
Figure 60. Europe Gabapentin Sales Market Share byType (2020-2025)
Figure 61. Europe Gabapentin Sales Market Share by Application (2020-2025)
Figure 62. Germany Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 63.France Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Gabapentin Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Gabapentin Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Gabapentin Sales Market Share by Application (2020-2025)
Figure 70. Egypt Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Gabapentin in 2025
Figure 76. Manufacturing Process Analysis of Gabapentin
Figure 77. Industry Chain Structure of Gabapentin
Figure 78. Channels of Distribution
Figure 79. Global Gabapentin Sales MarketForecast by Region (2026-2031)
Figure 80. Global Gabapentin Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Gabapentin Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Gabapentin Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Gabapentin Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Gabapentin Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gabapentin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Gabapentin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Gabapentin by Country/Region, 2020, 2024 & 2031
2.2 Gabapentin Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Gabapentin Sales by Type
2.3.1 Global Gabapentin Sales Market Share by Type (2020-2025)
2.3.2 Global Gabapentin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Gabapentin Sale Price by Type (2020-2025)
2.4 Gabapentin Segment by Application
2.4.1 Epilepsy
2.4.2 Neuropathic Pain
2.4.3 Restless Legs Syndrome
2.4.4 Others
2.5 Gabapentin Sales by Application
2.5.1 Global Gabapentin Sale Market Share by Application (2020-2025)
2.5.2 Global Gabapentin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Gabapentin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Gabapentin Breakdown Data by Company
3.1.1 Global Gabapentin Annual Sales by Company (2020-2025)
3.1.2 Global Gabapentin Sales Market Share by Company (2020-2025)
3.2 Global Gabapentin Annual Revenue by Company (2020-2025)
3.2.1 Global Gabapentin Revenue by Company (2020-2025)
3.2.2 Global Gabapentin Revenue Market Share by Company (2020-2025)
3.3 Global Gabapentin Sale Price by Company
3.4 Key Manufacturers Gabapentin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gabapentin Product Location Distribution
3.4.2 Players Gabapentin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GABAPENTIN BY GEOGRAPHIC REGION
4.1 World Historic Gabapentin Market Size by Geographic Region (2020-2025)
4.1.1 Global Gabapentin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Gabapentin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Gabapentin Market Size by Country/Region (2020-2025)
4.2.1 Global Gabapentin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Gabapentin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Gabapentin Sales Growth
4.4 APAC Gabapentin Sales Growth
4.5 Europe Gabapentin Sales Growth
4.6 Middle East & Africa Gabapentin Sales Growth
5 AMERICAS
5.1 Americas Gabapentin Sales by Country
5.1.1 Americas Gabapentin Sales by Country (2020-2025)
5.1.2 Americas Gabapentin Revenue by Country (2020-2025)
5.2 Americas Gabapentin Sales by Type (2020-2025)
5.3 Americas Gabapentin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gabapentin Sales by Region
6.1.1 APAC Gabapentin Sales by Region (2020-2025)
6.1.2 APAC Gabapentin Revenue by Region (2020-2025)
6.2 APAC Gabapentin Sales by Type (2020-2025)
6.3 APAC Gabapentin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gabapentin by Country
7.1.1 Europe Gabapentin Sales by Country (2020-2025)
7.1.2 Europe Gabapentin Revenue by Country (2020-2025)
7.2 Europe Gabapentin Sales by Type (2020-2025)
7.3 Europe Gabapentin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gabapentin by Country
8.1.1 Middle East & Africa Gabapentin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Gabapentin Revenue by Country (2020-2025)
8.2 Middle East & Africa Gabapentin Sales by Type (2020-2025)
8.3 Middle East & Africa Gabapentin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gabapentin
10.3 Manufacturing Process Analysis of Gabapentin
10.4 Industry Chain Structure of Gabapentin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gabapentin Distributors
11.3 Gabapentin Customer
12 WORLD FORECAST REVIEW FOR GABAPENTIN BY GEOGRAPHIC REGION
12.1 Global Gabapentin Market Size Forecast by Region
12.1.1 Global Gabapentin Forecast by Region (2026-2031)
12.1.2 Global Gabapentin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Gabapentin Forecast by Type (2026-2031)
12.7 Global Gabapentin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Gabapentin Product Portfolios and Specifications
13.1.3 Pfizer Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Assertio Therapeutics
13.2.1 Assertio Therapeutics Company Information
13.2.2 Assertio Therapeutics Gabapentin Product Portfolios and Specifications
13.2.3 Assertio Therapeutics Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Assertio Therapeutics Main Business Overview
13.2.5 Assertio Therapeutics Latest Developments
13.3 TEVA
13.3.1 TEVA Company Information
13.3.2 TEVA Gabapentin Product Portfolios and Specifications
13.3.3 TEVA Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 TEVA Main Business Overview
13.3.5 TEVA Latest Developments
13.4 Mylan
13.4.1 Mylan Company Information
13.4.2 Mylan Gabapentin Product Portfolios and Specifications
13.4.3 Mylan Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Mylan Main Business Overview
13.4.5 Mylan Latest Developments
13.5 Arbor Pharma
13.5.1 Arbor Pharma Company Information
13.5.2 Arbor Pharma Gabapentin Product Portfolios and Specifications
13.5.3 Arbor Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Arbor Pharma Main Business Overview
13.5.5 Arbor Pharma Latest Developments
13.6 Novartis
13.6.1 Novartis Company Information
13.6.2 Novartis Gabapentin Product Portfolios and Specifications
13.6.3 Novartis Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Novartis Main Business Overview
13.6.5 Novartis Latest Developments
13.7 Apotex
13.7.1 Apotex Company Information
13.7.2 Apotex Gabapentin Product Portfolios and Specifications
13.7.3 Apotex Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Apotex Main Business Overview
13.7.5 Apotex Latest Developments
13.8 Sun Pharmaceutical
13.8.1 Sun Pharmaceutical Company Information
13.8.2 Sun Pharmaceutical Gabapentin Product Portfolios and Specifications
13.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Sun Pharmaceutical Main Business Overview
13.8.5 Sun Pharmaceutical Latest Developments
13.9 Aurobindo Pharma
13.9.1 Aurobindo Pharma Company Information
13.9.2 Aurobindo Pharma Gabapentin Product Portfolios and Specifications
13.9.3 Aurobindo Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Aurobindo Pharma Main Business Overview
13.9.5 Aurobindo Pharma Latest Developments
13.10 Intas
13.10.1 Intas Company Information
13.10.2 Intas Gabapentin Product Portfolios and Specifications
13.10.3 Intas Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Intas Main Business Overview
13.10.5 Intas Latest Developments
13.11 Amneal
13.11.1 Amneal Company Information
13.11.2 Amneal Gabapentin Product Portfolios and Specifications
13.11.3 Amneal Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Amneal Main Business Overview
13.11.5 Amneal Latest Developments
13.12 Marksans Pharma
13.12.1 Marksans Pharma Company Information
13.12.2 Marksans Pharma Gabapentin Product Portfolios and Specifications
13.12.3 Marksans Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Marksans Pharma Main Business Overview
13.12.5 Marksans Pharma Latest Developments
13.13 Glenmark
13.13.1 Glenmark Company Information
13.13.2 Glenmark Gabapentin Product Portfolios and Specifications
13.13.3 Glenmark Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Glenmark Main Business Overview
13.13.5 Glenmark Latest Developments
13.14 Alkem
13.14.1 Alkem Company Information
13.14.2 Alkem Gabapentin Product Portfolios and Specifications
13.14.3 Alkem Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Alkem Main Business Overview
13.14.5 Alkem Latest Developments
13.15 Jiangsu Enhua
13.15.1 Jiangsu Enhua Company Information
13.15.2 Jiangsu Enhua Gabapentin Product Portfolios and Specifications
13.15.3 Jiangsu Enhua Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Jiangsu Enhua Main Business Overview
13.15.5 Jiangsu Enhua Latest Developments
13.16 Jiangsu Hengrui
13.16.1 Jiangsu Hengrui Company Information
13.16.2 Jiangsu Hengrui Gabapentin Product Portfolios and Specifications
13.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Jiangsu Hengrui Main Business Overview
13.16.5 Jiangsu Hengrui Latest Developments
13.17 Sailike
13.17.1 Sailike Company Information
13.17.2 Sailike Gabapentin Product Portfolios and Specifications
13.17.3 Sailike Gabapentin Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Sailike Main Business Overview
13.17.5 Sailike Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Gabapentin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Gabapentin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players ofTablet
Table 5. Global Gabapentin Sales byType (2020-2025) & (M Unit)
Table 6. Global Gabapentin Sales Market Share byType (2020-2025)
Table 7. Global Gabapentin Revenue byType (2020-2025) & ($ million)
Table 8. Global Gabapentin Revenue Market Share byType (2020-2025)
Table 9. Global Gabapentin Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Gabapentin Sale by Application (2020-2025) & (M Unit)
Table 11. Global Gabapentin Sale Market Share by Application (2020-2025)
Table 12. Global Gabapentin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Gabapentin Revenue Market Share by Application (2020-2025)
Table 14. Global Gabapentin Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Gabapentin Sales by Company (2020-2025) & (M Unit)
Table 16. Global Gabapentin Sales Market Share by Company (2020-2025)
Table 17. Global Gabapentin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Gabapentin Revenue Market Share by Company (2020-2025)
Table 19. Global Gabapentin Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Gabapentin Producing Area Distribution and Sales Area
Table 21. Players Gabapentin Products Offered
Table 22. Gabapentin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Gabapentin Sales by Geographic Region (2020-2025) & (M Unit)
Table 26. Global Gabapentin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Gabapentin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Gabapentin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Gabapentin Sales by Country/Region (2020-2025) & (M Unit)
Table 30. Global Gabapentin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Gabapentin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Gabapentin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Gabapentin Sales by Country (2020-2025) & (M Unit)
Table 34. Americas Gabapentin Sales Market Share by Country (2020-2025)
Table 35. Americas Gabapentin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Gabapentin Sales byType (2020-2025) & (M Unit)
Table 37. Americas Gabapentin Sales by Application (2020-2025) & (M Unit)
Table 38. APAC Gabapentin Sales by Region (2020-2025) & (M Unit)
Table 39. APAC Gabapentin Sales Market Share by Region (2020-2025)
Table 40. APAC Gabapentin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Gabapentin Sales byType (2020-2025) & (M Unit)
Table 42. APAC Gabapentin Sales by Application (2020-2025) & (M Unit)
Table 43. Europe Gabapentin Sales by Country (2020-2025) & (M Unit)
Table 44. Europe Gabapentin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Gabapentin Sales byType (2020-2025) & (M Unit)
Table 46. Europe Gabapentin Sales by Application (2020-2025) & (M Unit)
Table 47. Middle East & Africa Gabapentin Sales by Country (2020-2025) & (M Unit)
Table 48. Middle East & Africa Gabapentin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Gabapentin Sales byType (2020-2025) & (M Unit)
Table 50. Middle East & Africa Gabapentin Sales by Application (2020-2025) & (M Unit)
Table 51. Key Market Drivers & Growth Opportunities of Gabapentin
Table 52. Key Market Challenges & Risks of Gabapentin
Table 53. Key IndustryTrends of Gabapentin
Table 54. Gabapentin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Gabapentin Distributors List
Table 57. Gabapentin Customer List
Table 58. Global Gabapentin SalesForecast by Region (2026-2031) & (M Unit)
Table 59. Global Gabapentin RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Gabapentin SalesForecast by Country (2026-2031) & (M Unit)
Table 61. Americas Gabapentin Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Gabapentin SalesForecast by Region (2026-2031) & (M Unit)
Table 63. APAC Gabapentin Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Gabapentin SalesForecast by Country (2026-2031) & (M Unit)
Table 65. Europe Gabapentin RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Gabapentin SalesForecast by Country (2026-2031) & (M Unit)
Table 67. Middle East & Africa Gabapentin RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Gabapentin SalesForecast byType (2026-2031) & (M Unit)
Table 69. Global Gabapentin RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Gabapentin SalesForecast by Application (2026-2031) & (M Unit)
Table 71. Global Gabapentin RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Gabapentin Product Portfolios and Specifications
Table 74. Pfizer Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. AssertioTherapeutics Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 78. AssertioTherapeutics Gabapentin Product Portfolios and Specifications
Table 79. AssertioTherapeutics Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. AssertioTherapeutics Main Business
Table 81. AssertioTherapeutics Latest Developments
Table 82.TEVA Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 83.TEVA Gabapentin Product Portfolios and Specifications
Table 84.TEVA Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85.TEVA Main Business
Table 86.TEVA Latest Developments
Table 87. Mylan Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 88. Mylan Gabapentin Product Portfolios and Specifications
Table 89. Mylan Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Mylan Main Business
Table 91. Mylan Latest Developments
Table 92. Arbor Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 93. Arbor Pharma Gabapentin Product Portfolios and Specifications
Table 94. Arbor Pharma Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Arbor Pharma Main Business
Table 96. Arbor Pharma Latest Developments
Table 97. Novartis Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 98. Novartis Gabapentin Product Portfolios and Specifications
Table 99. Novartis Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Novartis Main Business
Table 101. Novartis Latest Developments
Table 102. Apotex Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 103. Apotex Gabapentin Product Portfolios and Specifications
Table 104. Apotex Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Apotex Main Business
Table 106. Apotex Latest Developments
Table 107. Sun Pharmaceutical Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 108. Sun Pharmaceutical Gabapentin Product Portfolios and Specifications
Table 109. Sun Pharmaceutical Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Sun Pharmaceutical Main Business
Table 111. Sun Pharmaceutical Latest Developments
Table 112. Aurobindo Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 113. Aurobindo Pharma Gabapentin Product Portfolios and Specifications
Table 114. Aurobindo Pharma Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Aurobindo Pharma Main Business
Table 116. Aurobindo Pharma Latest Developments
Table 117. Intas Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 118. Intas Gabapentin Product Portfolios and Specifications
Table 119. Intas Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. Intas Main Business
Table 121. Intas Latest Developments
Table 122. Amneal Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 123. Amneal Gabapentin Product Portfolios and Specifications
Table 124. Amneal Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Amneal Main Business
Table 126. Amneal Latest Developments
Table 127. Marksans Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 128. Marksans Pharma Gabapentin Product Portfolios and Specifications
Table 129. Marksans Pharma Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. Marksans Pharma Main Business
Table 131. Marksans Pharma Latest Developments
Table 132. Glenmark Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 133. Glenmark Gabapentin Product Portfolios and Specifications
Table 134. Glenmark Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 135. Glenmark Main Business
Table 136. Glenmark Latest Developments
Table 137. Alkem Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 138. Alkem Gabapentin Product Portfolios and Specifications
Table 139. Alkem Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 140. Alkem Main Business
Table 141. Alkem Latest Developments
Table 142. Jiangsu Enhua Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 143. Jiangsu Enhua Gabapentin Product Portfolios and Specifications
Table 144. Jiangsu Enhua Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 145. Jiangsu Enhua Main Business
Table 146. Jiangsu Enhua Latest Developments
Table 147. Jiangsu Hengrui Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 148. Jiangsu Hengrui Gabapentin Product Portfolios and Specifications
Table 149. Jiangsu Hengrui Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 150. Jiangsu Hengrui Main Business
Table 151. Jiangsu Hengrui Latest Developments
Table 152. Sailike Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors
Table 153. Sailike Gabapentin Product Portfolios and Specifications
Table 154. Sailike Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 155. Sailike Main Business
Table 156. Sailike Latest Developments
LIST OFFIGURES
Figure 1. Picture of Gabapentin
Figure 2. Gabapentin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gabapentin Sales Growth Rate 2020-2031 (M Unit)
Figure 7. Global Gabapentin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Gabapentin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Gabapentin Sales Market Share by Country/Region (2024)
Figure 10. Gabapentin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Capsule
Figure 12. Product Picture ofTablet
Figure 13. Global Gabapentin Sales Market Share byType in 2025
Figure 14. Global Gabapentin Revenue Market Share byType (2020-2025)
Figure 15. Gabapentin Consumed in Epilepsy
Figure 16. Global Gabapentin Market: Epilepsy (2020-2025) & (M Unit)
Figure 17. Gabapentin Consumed in Neuropathic Pain
Figure 18. Global Gabapentin Market: Neuropathic Pain (2020-2025) & (M Unit)
Figure 19. Gabapentin Consumed in Restless Legs Syndrome
Figure 20. Global Gabapentin Market: Restless Legs Syndrome (2020-2025) & (M Unit)
Figure 21. Gabapentin Consumed in Others
Figure 22. Global Gabapentin Market: Others (2020-2025) & (M Unit)
Figure 23. Global Gabapentin Sale Market Share by Application (2024)
Figure 24. Global Gabapentin Revenue Market Share by Application in 2025
Figure 25. Gabapentin Sales by Company in 2025 (M Unit)
Figure 26. Global Gabapentin Sales Market Share by Company in 2025
Figure 27. Gabapentin Revenue by Company in 2025 ($ millions)
Figure 28. Global Gabapentin Revenue Market Share by Company in 2025
Figure 29. Global Gabapentin Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Gabapentin Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Gabapentin Sales 2020-2025 (M Unit)
Figure 32. Americas Gabapentin Revenue 2020-2025 ($ millions)
Figure 33. APAC Gabapentin Sales 2020-2025 (M Unit)
Figure 34. APAC Gabapentin Revenue 2020-2025 ($ millions)
Figure 35. Europe Gabapentin Sales 2020-2025 (M Unit)
Figure 36. Europe Gabapentin Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Gabapentin Sales 2020-2025 (M Unit)
Figure 38. Middle East & Africa Gabapentin Revenue 2020-2025 ($ millions)
Figure 39. Americas Gabapentin Sales Market Share by Country in 2025
Figure 40. Americas Gabapentin Revenue Market Share by Country (2020-2025)
Figure 41. Americas Gabapentin Sales Market Share byType (2020-2025)
Figure 42. Americas Gabapentin Sales Market Share by Application (2020-2025)
Figure 43. United States Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Gabapentin Sales Market Share by Region in 2025
Figure 48. APAC Gabapentin Revenue Market Share by Region (2020-2025)
Figure 49. APAC Gabapentin Sales Market Share byType (2020-2025)
Figure 50. APAC Gabapentin Sales Market Share by Application (2020-2025)
Figure 51. China Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 55. India Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Gabapentin Sales Market Share by Country in 2025
Figure 59. Europe Gabapentin Revenue Market Share by Country (2020-2025)
Figure 60. Europe Gabapentin Sales Market Share byType (2020-2025)
Figure 61. Europe Gabapentin Sales Market Share by Application (2020-2025)
Figure 62. Germany Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 63.France Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Gabapentin Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Gabapentin Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Gabapentin Sales Market Share by Application (2020-2025)
Figure 70. Egypt Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Gabapentin Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Gabapentin in 2025
Figure 76. Manufacturing Process Analysis of Gabapentin
Figure 77. Industry Chain Structure of Gabapentin
Figure 78. Channels of Distribution
Figure 79. Global Gabapentin Sales MarketForecast by Region (2026-2031)
Figure 80. Global Gabapentin Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Gabapentin Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Gabapentin Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Gabapentin Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Gabapentin Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Gabapentin Drug Market Growth 2025-2031
US$ 3,660.00
October 2025
153 pages
Global Gabapentin Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
US$ 3,480.00
July 2025
145 pages
Global and Chinese Gabapentin Market Outlook 2017-2022
US$ 2,800.00
March 2017
98 pages
